Building Predictive Models Of Clinical Outcomes In Immune Oncology Using Computational Tissue Analysis Scorecards
Key takeaways Building Predictive Models of Clinical Outcomes in Immune Oncology Using Computational Tissue Analysis Scorecards The spatial location of PD-L1 expression can identify patients
Combined Immunohistochemistry And NGS-Based Patient Profiling For Predicting Anti-PD-1/PD-L1 Therapy Response
Key Takeaways Successful pathology AI does not replace, but assist pathologists in high-complexity tissue analysis Transparency and control is retained in a pathologist-centric AI-based system
Analysis of Companion Diagnostic Potentials For Multifaceted PD-L1 Assays
ABSTRACT In vitro diagnostic (IVD) approvals of qualitative immunohistochemical (IHC) assays offer unique patient selection strategies by equipping pathologists with new tools to assess tumor
Artificial Intelligence Assisted Macrophage Identification in Tumor Biopsies
Key Takeaways Classifying macrophages is important in understanding response to immunotherapy, but it may be challenging to do by eye Using an immunofluorescence-guided machine learning
Pathologists Versus AI
Artificial intelligence (AI) systems for pathology may appear to compete with manual pathology, as they enable the assessment of thousands of cells and application of
CIOReview Names Flagship Company of the Year
CIOReview named Flagship Biosciences “Company of the Year,” as part of the publication’s 2018 20 Most Promising Pharma & Life Sciences Tech Solution Providers industry
